PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Heart Center, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.\', \'Section of Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.\', \'Department of Endocrinology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.\', \'Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.\', \'Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.\', \'Department of Cardiovascular Epidemiology and Research, The Danish Heart Foundation, Copenhagen, Denmark.\', \'Department of Clinical Epidemiology and Department of Cardiology, Hillerød Hospital, Hillerød, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jama.2020.11301
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 32558877
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all